F12.21
Cannabis dependence, in remission
Clinical Classification Guidelines
Inclusion Terms
- Cannabis use disorder, moderate, in early remission
- Cannabis use disorder, moderate, in sustained remission
- Cannabis use disorder, severe, in early remission
- Cannabis use disorder, severe, in sustained remission
Medical Intelligence & Overview
ICD-10 code F12.21 pertains to cannabis dependence that is currently in remission. This classification indicates that an individual previously experienced a significant level of cannabis use disorder, whether moderate or severe, but is now in a period of abstinence and recovery. The term 'in remission' refers to the reduction or disappearance of signs and symptoms associated with cannabis dependence, although the history of the disorder remains important for ongoing health management. Knowing more about this condition can help individuals and healthcare providers to support sustained recovery and understand potential risks of relapse.
Causes & Symptoms
Clinical Causes: Chronic or heavy cannabis use leading to physical and psychological dependence. Use of cannabis as a way to cope with stress, anxiety, depression, or other mental health issues. Genetic predisposition towards substance dependence. Environmental factors, including peer pressure or social environments encouraging cannabis use. Lack of awareness or access to resources for substance abuse treatment.
Key Symptoms: Difficulty controlling or reducing cannabis use. Craving or intense desire to consume cannabis. Neglecting responsibilities or activities due to cannabis use. Continued use despite negative physical, mental, or social consequences. Tolerance, meaning increased amounts are needed to achieve the same effect. Withdrawal symptoms when not using cannabis, such as irritability, anxiety, or sleep disturbances.
Diagnostic & Treatment
Diagnosis Path: Diagnosis of cannabis dependence in remission is typically made through clinical assessments by healthcare professionals. They review the patient's history of cannabis use, symptoms of dependence, and any previous treatments. The clinician will ascertain that the individual meets criteria for cannabis use disorder in the past but is currently not experiencing active symptoms. Additional tools, such as questionnaires or interviews, may be employed to confirm the remission status and evaluate ongoing risk factors.
Treatment Protocols: Counseling or psychotherapy, such as cognitive-behavioral therapy (CBT), to develop coping strategies and prevent relapse. Support groups or peer support networks that provide encouragement and accountability. Addressing mental health issues that may have contributed to substance use, including therapy or medication if necessary. Education about the risks of relapse and strategies to manage triggers. Monitoring for any signs of returning dependence, with periodic check-ins from healthcare providers.
Clinical Advice & FAQs
Billing Guidance
Is F12.21 a billable ICD-10 code?
Yes, F12.21 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report F12.21?
Clinical documentation must specify the nature of Cannabis dependence, in remission and any associated comorbidities for accurate reporting.
Cite this Clinical Reference
